WAYNE, Pa., Sept. 21, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), ?a dermatologist-led
biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to address significant unmet
needs in aesthetic and medical dermatology and immunology, today announced that management will attend the following conference:
- Dr. Neal Walker, President and Chief Executive Officer, will present at the 2018 Cantor Global Healthcare Conference in New
York, NY on Wednesday, October 3, 2018 at 9:45 AM EST. Management will also host investor meetings on Wednesday, October 3,
2018.
A live webcast of the 2018 Cantor Global Healthcare Conference presentation may be accessed through the Company's web site,
www.aclaristx.com, on the 'Events and Presentations' section. An archived version of the presentation will be available for 30
days.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing
innovative therapies to address significant unmet needs in aesthetic and medical dermatology and immunology. Aclaris’ focus on
market segments with no FDA-approved medications or where treatment gaps exist has resulted in the first FDA-approved treatment for
raised SKs and several clinical programs to develop medications for the potential treatment of common warts, alopecia areata, and
vitiligo. For additional information, please visit www.aclaristx.com and follow Aclaris on LinkedIn.
Aclaris Contact
Michael Tung, M.D.
Senior Vice President
Corporate Strategy/Investor Relations
484-329-2140
mtung@aclaristx.com
